D018797Chemicals & DrugsD12.776.16716170.989541Cell Cycle ProteinsFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation Resourcevivo:orcidIdORCID idPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson0.43640.020063816research area of0.6052340.079699719subject area fortrue1Associate ProfessorAssociate Professor20427671Halawani D, Tessier S, Anzellotti D, Bennett DA, Latterich M, LeBlanc ACThe Journal of neuroscience : the official journal of the Society for NeuroscienceIdentification of Caspase-6-mediated processing of the valosin containing protein (p97) in Alzheimer's disease: a novel link to dysfunction in ubiquitin proteasome system-mediated protein degradation. J Neurosci. 2010 Apr 28; 30(17):6132-42.J Neurosci2010-04-28T00:00:002010Identification of Caspase-6-mediated processing of the valosin containing protein (p97) in Alzheimer's disease: a novel link to dysfunction in ubiquitin proteasome system-mediated protein degradation.PhilipBonomiPhilip Bonomi349183Bonomi, PhilipProfessorCarlMakiCarl Maki349531Maki, CarlProfessorLenaAl-HarthiLena Al-Harthi41.87386750000000-87.67102690000000349563Al-Harthi, Lena0000-0003-3915-3904ProfessorEdBarkerEd Barker41.87386750000000-87.67102690000000349564Barker, EdProfessorSashaShafikhaniSasha H. Shafikhani41.87386750000000-87.67102690000000349571Shafikhani, SashaAssociate Professor5Associate Professor4Professor20124487Yin P, Lin Z, Reierstad S, Wu J, Ishikawa H, Marsh EE, Innes J, Cheng Y, Pearson K, Coon JS, Kim JJ, Chakravarti D, Bulun SECancer researchTranscription factor KLF11 integrates progesterone receptor signaling and proliferation in uterine leiomyoma cells. Cancer Res. 2010 Feb 15; 70(4):1722-30.Cancer Res2010-02-02T00:00:002010Transcription factor KLF11 integrates progesterone receptor signaling and proliferation in uterine leiomyoma cells.19798433Ward J, Davis Z, DeHart J, Zimmerman E, Bosque A, Brunetta E, Mavilio D, Planelles V, Barker EPLoS pathogensHIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage response. PLoS Pathog. 2009 Oct; 5(10):e1000613.PLoS Pathog2009-10-02T00:00:002009HIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage response.22674979Henderson LJ, Narasipura SD, Adarichev V, Kashanchi F, Al-Harthi LJournal of virologyIdentification of novel T cell factor 4 (TCF-4) binding sites on the HIV long terminal repeat which associate with TCF-4, ?-catenin, and SMAR1 to repress HIV transcription. J Virol. 2012 Sep; 86(17):9495-503.J Virol2012-06-06T00:00:002012Identification of novel T cell factor 4 (TCF-4) binding sites on the HIV long terminal repeat which associate with TCF-4, ?-catenin, and SMAR1 to repress HIV transcription.Anatomy and Cell BiologyRush University, Rush Medical Collegetrue1ProfessorProfessorInternal Medicine, Division of Hematology/Oncology/Cell Therapytrue1ProfessorProfessor28212994Awad MM, Chu QS, Gandhi L, Stephenson JJ, Govindan R, Bradford DS, Bonomi PD, Ellison DM, Eaton KD, Fritsch H, Munzert G, Johnson BE, Socinski MALung cancer (Amsterdam, Netherlands)An open-label, phase II study of the polo-like kinase-1 (Plk-1) inhibitor, BI 2536, in patients with relapsed small cell lung cancer (SCLC). Lung Cancer. 2017 02; 104:126-130.Lung Cancer2016-12-30T00:00:002016An open-label, phase II study of the polo-like kinase-1 (Plk-1) inhibitor, BI 2536, in patients with relapsed small cell lung cancer (SCLC).Internal Medicine, Division of Hematology, Oncology and Cell Therapytrue1ProfessorProfessorMicrobial Pathogens and Immunitytrue1ProfessorProfessor